PACAP (1-38), human, ovine, rat
Code | Size | Price |
---|
TAR-TP1878-1mg | 1mg | £188.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-TP1878-5mg | 5mg | £422.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
PACAP 1-38 is a neuropeptide with 38 amino acid residues.
CAS:
137061-48-4
Formula:
C203H331N63O53S
Molecular Weight:
4534.26
Purity:
0.98
SMILES:
0
References
Gourlet P, et al. Fragments of pituitary adenylate cyclase activating polypeptide discriminate between type I and II recombinant receptors. Eur J Pharmacol. 1995 Dec 4;287(1):7-11.
Gourlet P , Andr? Vandermeers, Vandermeers-Piret M C , et al. Fragments of pituitary adenylate cyclase activating polypeptide discriminate between type I and II recombinant receptors[J]. European Journal of Pharmacology, 1995, 287(1):0-11.
Akira Arimura, Min Li, Vecihi Batuman.Potential Protective Action of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP38) on in Vitro and in Vivo Models of Myeloma Kidney Injury .2006 Jan 15;107(2):661-8.